Relationship among CT-based abdominal adipose tissue areas and pancreatic ductal adenocarcinoma in male

References

• Paternoster S, Falasca M. The intricate relationship between diabetes, obesity and pancreatic cancer. Biochim Biophys Acta Rev Cancer. 2020;1873(1):188326.
   PubMed Web of Science ®Google Scholar
• Ilic M, Ilic I. Epidemiology of pancreatic cancer. World J Gastroenterol. 2016;22(44):9694–9705.
   PubMed Web of Science ®Google Scholar
• Hidalgo M. Pancreatic cancer. N Engl J Med. 2010;362(17):1605–1617.
   PubMed Web of Science ®Google Scholar
• Chari ST. Detecting early pancreatic cancer: problems and prospects. Semin Oncol. 2007;34(4):284–294.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.
   PubMed Web of Science ®Google Scholar
• Midha S, Chawla S, Garg PK. Modifiable and non-modifiable risk factors for pancreatic cancer: A review. Cancer Lett. 2016;381(1):269–277.
   PubMed Web of Science ®Google Scholar
• Cascetta P, Cavaliere A, Piro G, et al. Pancreatic cancer and obesity: molecular mechanisms of cell transformation and chemoresistance. IJMS. 2018;19(11):3331.
   Web of Science ®Google Scholar
• Coelho M, Oliveira T, Fernandes R. Biochemistry of adipose tissue: an endocrine organ. Arch Med Sci. 2013;9(2):191–200.
   PubMed Web of Science ®Google Scholar
• Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444(7121):881–887.
   PubMed Web of Science ®Google Scholar
• Goh VH, Hart WG. Association of general and abdominal obesity with age, endocrine and metabolic factors in Asian men. Aging Male. 2016;19(1):27–33.
   PubMed Web of Science ®Google Scholar
• Angelova P, Kamenov Z, Tsakova A, et al. Interleukin-18 and testosterone levels in men with metabolic syndrome. Aging Male. 2018;21(2):130–137.
   PubMed Web of Science ®Google Scholar
• Mohamad NV, Wong SK, Wan Hasan WN, et al. The relationship between circulating testosterone and inflammatory cytokines in men. Aging Male. 2019;22(2):129–140.
   PubMed Web of Science ®Google Scholar
• Khandekar MJ, Cohen P, Spiegelman BM. Molecular mechanisms of cancer development in obesity. Nat Rev Cancer. 2011;11(12):886–895.
   PubMed Web of Science ®Google Scholar
• Wörmann SM, Algül H. Risk factors and therapeutic targets in pancreatic cancer. Front Oncol. 2013;3:282.
   PubMedGoogle Scholar
• Hu Z, Wu J, Lai S, et al. Clear cell renal cell carcinoma: the value of sex-specific abdominal visceral fat measured on CT for prediction of Fuhrman nuclear grade [published online ahead of print, 2020 Mar. Eur Radiol. 2020;30(7):3977–3986.
   PubMed Web of Science ®Google Scholar
• Greco F, Mallio CA, Grippo R, et al. Increased visceral adipose tissue in male patients with non-clear cell renal cell carcinoma. Radiol Med. 2020;125(6):538–543.
   PubMed Web of Science ®Google Scholar
• Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev. 2010;11(1):11–18.
   PubMed Web of Science ®Google Scholar
• Greco F, Mallio CA, Cirimele V, et al. Imaging of renal angiomyolipomatosis. jrenhep. 2018;2(2):10–19.
   Google Scholar
• Greco F, Quarta LG, Grasso RF, et al. Increased visceral adipose tissue in clear cell renal cell carcinoma with and without peritumoral collateral vessels. Br J Radiol. 2020;93:20200334. [published online ahead of print].
   Google Scholar
• Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23(5):469–480.
   PubMed Web of Science ®Google Scholar
• Groti K, Žuran I, Antonič B, et al. The impact of testosterone replacement therapy on glycemic control, vascular function, and components of the metabolic syndrome in obese hypogonadal men with type 2 diabetes. Aging Male. 2018;21(3):158–169.
   PubMed Web of Science ®Google Scholar
• Yoshizumi T, Nakamura T, Yamane M, et al. Abdominal fat: standardized technique for measurement at CT. Radiology. 1999; 211(1):283–286.
   PubMed Web of Science ®Google Scholar
• Borkan GA, Gerzof SG, Robbins AH, et al. Assessment of abdominal fat content by computed tomography. Am J Clin Nutr. 1982;36(1):172–177.
   PubMed Web of Science ®Google Scholar
• Aune D, Greenwood DC, Chan DSM, et al. Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies. Ann Oncol. 2012;23(4):843–852.
   PubMed Web of Science ®Google Scholar
• Larsson SC, Permert J, Håkansson N, et al. Overall obesity, abdominal adiposity, diabetes and cigarette smoking in relation to the risk of pancreatic cancer in two Swedish population-based cohorts. Br J Cancer. 2005;93(11):1310–1315.
   PubMed Web of Science ®Google Scholar
• Arslan AA, Helzlsouer KJ, Kooperberg C, et al. Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med. 2010;170(9):791–802.
   PubMedGoogle Scholar
• Kwee TC, Kwee RM. Abdominal adiposity and risk of pancreatic cancer. Pancreas. 2007;35(3):285–286.
   PubMed Web of Science ®Google Scholar
• Kuk JL, Church TS, Blair SN, et al. Does measurement site for visceral and abdominal subcutaneous adipose tissue alter associations with the metabolic syndrome? Diabetes Care. 2006;29(3):679–684.
   PubMed Web of Science ®Google Scholar
• Duarte MF, Luis C, Baylina P, et al. Clinical and metabolic implications of obesity in prostate cancer: is testosterone a missing link? Aging Male. 2019;22(4):228–240.
   PubMed Web of Science ®Google Scholar
• Mathur A, Hernandez J, Shaheen F, et al. Preoperative computed tomography measurements of pancreatic steatosis and visceral fat: prognostic markers for dissemination and lethality of pancreatic adenocarcinoma. HPB (Oxford). 2011;13(6):404–410.
   PubMed Web of Science ®Google Scholar
• Greco F, Cirimele V, Mallio CA, et al. Increased visceral adipose tissue in male patients with clear cell renal cell carcinoma. Clin Cancer Investig J. 2018;7(4):132–136.
   Web of Science ®Google Scholar
• Massl R, Blankenstein M, Jeurnink S, et al. Visceral adipose tissue: the link with esophageal adenocarcinoma. Scand J Gastroenterol. 2014;49(4):449–457.
   PubMed Web of Science ®Google Scholar
• Montano-Loza AJ, Mazurak VC, Ebadi M, et al. Visceral adiposity increases risk for hepatocellular carcinoma in male patients with cirrhosis and recurrence after liver transplant. Hepatology. 2018;67(3):914–923.
   PubMed Web of Science ®Google Scholar
• Oh TH, Byeon JS, Myung SJ, et al. Visceral obesity as a risk factor for colorectal neoplasm. J Gastroenterol Hepatol. 2008;23(3):411–417.
   PubMed Web of Science ®Google Scholar
• von Hafe P, Pina F, Pérez A, et al. Visceral fat accumulation as a risk factor for prostate cancer. Obes Res. 2004;12(12):1930–1935.
   PubMedGoogle Scholar
• Nedungadi TP, Clegg DJ. Sexual dimorphism in body fat distribution and risk for cardiovascular diseases. J Cardiovasc Transl Res. 2009;2(3):321–327.
   PubMed Web of Science ®Google Scholar